Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments
As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to […]
Can’t see the audio player? Click here to listen on SoundCloud. You can also listen on Spotify, Apple Podcasts, Stitcher, […] Desperation led José Luis Hernández to ride atop a speeding train through northern Mexico with hopes of reaching the United […] DUBLIN, Aug. 12, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration […] TITUSVILLE, N.J. – July 30, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. […] Can’t see the audio player? Click here to listen on SoundCloud. You can also listen on Spotify, Apple Podcasts, Stitcher, […] In his multiple attempts to overcome a methamphetamine addiction that ground through two decades of his life, Tyrone Clifford Jr. […] June 21, 2021 — Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children […] Nurtec ODT 75 mg is the first oral CGRP antagonist approved to prevent migraine Nurtec ODT 75 mg is now […] HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio […]Medications
KHN’s ‘What the Health?’: The Autumn of Democrats’ Discontent
No Papers, No Care: Disabled Migrants Seek Help Through Lawsuit, Activism
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults
Uptravi (selexipag) Receives FDA Approval for Intravenous Use in Adult Patients with Pulmonary Arterial Hypertension (PAH)
KHN’s ‘What the Health?’: Hot Covid Summer
California Lawmakers Push Feds to Allow a Therapy That Pays Meth Users to Abstain
FDA Approves Pradaxa (dabigatran) as First Oral Blood Thinning Medication for Children
FDA Approves Biohaven’s Nurtec ODT (rimegepant) for Preventative Treatment of Migraine
Kiniksa Announces FDA Approval of Arcalyst (rilonacept) for Recurrent Pericarditis